Supernus Pharmaceuticals (SUPN) dives 16% after pricing a 6M secondary at just $8/share. The...

|About: Supernus Pharmaceuticals... (SUPN)|By:, SA News Editor

Supernus Pharmaceuticals (SUPN) dives 16% after pricing a 6M secondary at just $8/share. The stock was trading at $11 late yesterday afternoon. (PR)